Gregg Wallis, PhD, CMgr.
Gregg Wallis is an R&D departmental manager for the Binding Site Group Ltd (Birmingham, UK), with responsibility for early-phase immunodiagnostic assay development and protein analysis. Prior to joining the Binding Site in 2004, Dr Wallis worked as a Senior Scientist for a French Biopharmaceutical company. Dr Wallis obtained a doctorate in Biochemistry from the Imperial College of science, technology & medicine (University of London) in 1993, and is a Chartered member of the Chartered Management Institute.